PE firm Ampersand acquires German CDMO Vibalogics 03-Jun-2019 By Maggie Lynch The private equity firm Ampersand Capital has acquired Vibalogics with plans to increase development and manufacturing capabilities for complex viral products.
PE firm buys GSK spinoff Neomed-Labs as it looks to ‘flip the next page’ of its story 06-Sep-2018 By Melissa Fassbender Neomed-Labs is aiming to double in size and become a global leader in clinical immunology lab services with an investment from Ampersand Capital.